 NEW YORK, April 07, 2022 GLOBE NEWSWIRE -- Anavex Life Sciences Corp. Anavex or the Company Nasdaq: AVXL, a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimers disease, Parkinsons disease, Rett syndrome and other central nervous system CNS diseases, today announced that Anavex Management Team will present at the 21st Annual Needham Virtual Healthcare Conference on Thursday, April 14, 2022, at 3:45 PM ET. 